Good news | Scientific researφε>↑ch and innovation continue to make strΩ>₹ides! Haibu Pharmaceutical has obta♦★ined another patent autho→×αrization.
Classification:
Company News
Release time:
2024-05-15
On April 12, the patent "Hydrogel≠σ♥ and its Production Method ≤♣←" applied for by Haibu Pharmace®'↓utical was granted patent authori↓≥£zation by the National"<→₩ Intellectual Property Administrat±¶•ion! The acquisition of this patent onc♣£e again demonstrates Haibu ↕Pharmaceutical's research fo↔<undation and technological innovat≈£ion strength.
Total number of patent appl&ications: 61
Authorized patents: 16
Patents have become a core element in ↔∏♠market competition as an impo¶¥rtant intellectual proper₽"★ty.In the future, Haibu ≥&Pharmaceutical will continue ♠ ₹♥to increase investment ₹in research and development and tδφalent cultivation, strengthen δ₩research innovation advantages, enh₽¥♥←ance technological innova∏≈σtion capabilities, promote the£Ω¶ transformation of sc§→λientific achievements intoε↓☆↕ practical application₩©s, provide strong technicaδ©<l support for company projects, ↓©₽∑continuously improve customer se✔ ♥rvice quality and efficiency to meet dγ≥iversified market demaλ♦∏nds.
Beijing Haibu Pharmaceutical Te↔←chnology Co., Ltd. (referred©γ¶ to as "Haibu Pharmaceutical") was esδ™×tablished in 2005 an d is a high-tech enterprise with ★÷♣"chemical drug R&D" as its core≠✔ capability. It has a research center σδ≤≤in Beijing, an active♥≈♦ pharmaceutical ingredieβα$nt (API) and formulation pi♥lot verification center, and a∏ε GMP industrial production base. It ma↕Ωinly engages in CRO services for A₹Ω λPIs and formulations, MAHΩ joint licensing, API-related ap£≤↕plications, and commerci™γal supply of pharmaceut∏↑ical intermediates.It has rich experience i∏ n R&D transfer production registrat÷₹πion applications for vari←¥€☆ous dosage forms such as che≤✘mical raw materials drugs, ¶§←¥oral solids, liquid preparations, s€≠α™terile injections, exte↓✘rnal preparations etc. The R&aσ✔↑§mp;D products cover ♦→multiple therapeutic areas includπε★"ing anti-tumor, anti-depression, a$•§♦nti-epilepsy, anti-anxiety cardiovascσ§ular diseases digestive system respir™≈atory system etc.
Haibu Pharmaceutical has been awa±α±rded the title of "Top 20 Chinese ✔ Pharmaceutical R&D Companie←γ®♥s" for many consecutive years π"×∏and recognized as a "Speci£β♠↑alized & Innovative Enterprise" ™÷®≠in Beijing,"National High-£₹'÷tech Enterprise", "Beijing S≠×∑cience & Technology §™ΩResearch Development Institution"", "Beijing Yizhuang ¥γ"♦Enterprise Innovation Center"± , etc.
Beijing Hope Pharmaceuti ↑↑♥cal Co., Ltd.
